June 30, 2020
Oncopeptides submits a New Drug Application to the FDA for accelerated approval of melflufen in triple-class refractory multiple myeloma patients
Media
June 30, 2020
Nordic Nanovector to amend PARADIGME trial protocol to expand eligible patient population
June 29, 2020
Oncopeptides strengthens the pre-clinical development and takes over Kancera´s Solna-based laboratory for drug development as of July 1
June 29, 2020
Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors
June 29, 2020
Nordic Nanovector’s Betalutin® Receives Fast-Track Designation from US FDA for Marginal Zone Lymphoma
June 29, 2020
Targovax and Oblique enter collaboration to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms
June 25, 2020
Fusion Pharmaceuticals Announces Pricing Of Initial Public Offering
June 24, 2020
Targovax announces presentation of pre-clinical data from Next Generation ONCOS at AACR Virtual Annual Conference
June 23, 2020
Vicore Pharma expands recruitment base for the ATTRACT study
June 23, 2020
Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA® in mesothelioma